Manel Juan

Head of Immunology service/department

Hospital Clínic de Barcelona

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Immunology Immunology professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2024

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (7)

Pedro Castro Rebollo

Associate Professor

University of Barcelona

SPAIN

View details

Lorena Pérez Amill

Glyscend Therapeutics

SPAIN

View details

Ana Arance

University of Barcelona

SPAIN

View details

VITTORIO SAMBRI

Associate Professor Of Microbiology

University of Bologna

ITALY

View details

Jordi Canes

Scientific Manager Head

SPAIN

View details

Xavier Gonzàlez Farré

Associate professor

Universitat Internacional de Catalunya

SPAIN

View details

ENRIQUETA FELIP

Head Thoracic Oncology Unit (After Competitive Exam)

Hospital Universitari Vall d'Hebron

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Manel Juan

Research Interests

Explore related searches

Contact this professor

Articles (10)

Lymphocyte T Subsets and Outcome of Immune Checkpoint Inhibitors in Melanoma Patients: An Oncologist’s Perspective on Current Knowledge

T-Cell Receptor Repertoire Sequencing and Its Applications: Focus on Infectious Diseases and Cancer

SOLTI-1904 ACROPOLI TRIAL: efficacy of spartalizumab monotherapy across tumor-types expressing high levels of <i>PD1</i> mRNA

Epigenetic Profiling and Response to CD19 Chimeric Antigen Receptor T-Cell Therapy in B-Cell Malignancies

Immunotherapy in Advanced Prostate Cancer: Current Knowledge and Future Directions

Manufacture of adoptive cell therapies at academic cancer centers: scientific, safety and regulatory challenges

Factors associated with the clinical outcome of patients with relapsed/refractory CD19<sup>+</sup> acute lymphoblastic leukemia treated with ARI-0001 CART19-cell therapy.

CD137 Costimulation Counteracts TGFβ Inhibition of NK-cell Antitumor Function

First report of CART treatment in AL amyloidosis and relapsed/refractory multiple myeloma

Inmunología en COVID-19; mucho más allá del diagnóstico de la infección o de la vacunación

Collaborators (7)

Pedro Castro Rebollo

Lorena Pérez Amill

Ana Arance

VITTORIO SAMBRI

Jordi Canes

Xavier Gonzàlez Farré

ENRIQUETA FELIP

Make your next move.